CATHERINE DELSECCO: Open Payments
NPI 1720150105 · MERCER ISLAND, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,677 in 91 payments from 14 companies in 2025. Trend: 2023 $1,335 · 2024 $1,768 · 2025 $1,677
Food & beverage: $1,677
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 31 | $391 |
| ABBVIE INC. | 20 | $389 |
| Janssen Biotech, Inc. | 8 | $214 |
| Galderma Laboratories, L.P. | 5 | $116 |
| Lilly USA, LLC | 5 | $113 |
| Organogenesis Inc. | 4 | $80 |
| UCB, Inc. | 4 | $77 |
| GENZYME CORPORATION | 3 | $67 |
| Arcutis Biotherapeutics, Inc. | 4 | $66 |
| Organon LLC | 2 | $41 |
Products named: COSENTYX, TREMFYA, SKYRIZI, RINVOQ, TALTZ, NEMLUVIO, Bimzelx, DUPIXENT.
Industry payments across WA — which companies pay providers there.
